3.46

6.49% -0.24

Cns Pharmaceuticals Inc (CNSP)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$3.70

Aprire:

$3.55

Volume 24 ore:

11,128

Relative Volume:

0.33

Capitalizzazione di mercato:

$2.15M

Reddito:

Utile/perdita netta:

$-17.06M

Rapporto P/E:

-0.0489

EPS:

-70.7173

Flusso di cassa netto:

$-14.18M

1 W Prestazione:

-23.28%

1M Prestazione:

-43.65%

6M Prestazione:

-49.04%

1 anno Prestazione:

-94.65%

Intervallo 1D:

$3.41

$3.63

Intervallo di 1 settimana:

$3.41

$4.62

Portata 52W:

$3.41

$114.00

Cns Pharmaceuticals Inc Stock (CNSP) Company Profile

Nome

Cns Pharmaceuticals Inc

Settore

Healthcare (1111)

Industria

Biotechnology (622)

Telefono

1-800-946-9185

Indirizzo

2100 WEST LOOP SOUTH, HOUSTON

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-13

Ultimi documenti SEC

CNSP's Discussions on Twitter

Compare CNSP vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CNSP Cns Pharmaceuticals Inc	3.46	2.30M	0	-17.06M	-14.18M	-70.72
VRTX Vertex Pharmaceuticals Inc	491.47	117.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	803.17	82.85B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	821.96	51.58B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	314.40	40.75B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.07	38.33B	4.98B	69.60M	525.67M	0.5198

Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-12-28	Downgrade	Ladenburg Thalmann	Buy → Neutral
2020-08-24	Iniziato	Ladenburg Thalmann	Buy

Cns Pharmaceuticals Inc Borsa (CNSP) Ultime notizie

12:29 PM

How CNS Pharmaceuticals Inc. stock performs in weak economy2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - mfd.ru

12:29 PM

Feb 12, 2026

What are analysts’ price targets for CNS Pharmaceuticals Inc.July 2025 Opening Moves & Long Hold Capital Preservation Tips - mfd.ru

Feb 12, 2026

Why CNS Pharmaceuticals Inc. stock is recommended by analystsInsider Selling & Entry Point Strategy Guides - mfd.ru

Feb 12, 2026

CNS Pharmaceuticals (NASDAQ:CNSP) Shares Down 11.2% – Here’s What Happened - Defense World

Feb 12, 2026

Feb 10, 2026

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook on CNS Drug Innovator with 19.56% Upside Potential - DirectorsTalk Interviews

Feb 10, 2026

Feb 08, 2026

CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D - MSN

Feb 08, 2026

Growth Report: Will Origin Bancorp Inc outperform the market in YEARPrice Action & Community Verified Trade Signals - baoquankhu1.vn

Feb 08, 2026

Weekly Trades: Why is CNS Pharmaceuticals Inc stock going downJuly 2025 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 08, 2026

Feb 05, 2026

Aug Catalysts: Will CNS Pharmaceuticals Inc outperform small cap indexesQuarterly Earnings Summary & Weekly Hot Stock Watchlists - baoquankhu1.vn

Feb 05, 2026

Feb 03, 2026

Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals - GlobeNewswire

Feb 03, 2026

Feb 01, 2026

CNS Pharmaceuticals shares dip after CEO departure announcement - MSN

Feb 01, 2026

Jan 27, 2026

CNS Pharmaceuticals says priority ‘is to transform’ how company operates - TipRanks

Jan 27, 2026

CNS Pharmaceuticals’ new CEO outlines strategic overhaul By Investing.com - Investing.com Canada

Jan 27, 2026

CNS Pharmaceuticals (NASDAQ: CNSP) Issues Shareholder Letter Outlining Strategic Review and Focus on TPI 287 - Digital Journal

Jan 27, 2026

CNS Pharmaceuticals Announces Strategic Review Focused on Lead Drug Candidate TPI 287 - citybuzz -

Jan 27, 2026

New CNS Pharmaceuticals CEO launches broad review built around lead cancer drug - stocktitan.net

Jan 27, 2026

Jan 26, 2026

Ovid Therapeutics: Bullish Post-PIPE With 2 Differentiated CNS Moonshots - Seeking Alpha

Jan 26, 2026

Jan 23, 2026

Breakout Move: Is CNS Pharmaceuticals Inc stock good for income investorsMarket Volume Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Jan 23, 2026

Jan 21, 2026

CNS Pharmaceuticals (NASDAQ:CNSP) Stock Price Up 3.3% – What’s Next? - Defense World

Jan 21, 2026

Jan 19, 2026

Is CNS Pharmaceuticals Inc. being accumulated by smart money2025 Major Catalysts & Precise Buy Zone Identification - bollywoodhelpline.com

Jan 19, 2026

Jan 15, 2026

CNS Pharma Stock Up Over 30% - Nasdaq

Jan 15, 2026

Jan 12, 2026

Weekly Trades: Is CNS Pharmaceuticals Inc in a long term uptrendJuly 2025 Fed Impact & Verified Short-Term Plans - baoquankhu1.vn

Jan 12, 2026

Jan 09, 2026

How CNS Pharmaceuticals Inc. stock compares to market leadersForecast Cut & AI Optimized Trading Strategy Guides - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

How CNS Pharmaceuticals Inc. stock reacts to global recession fears2025 Price Targets & Growth Focused Investment Plans - Улправда

Jan 08, 2026

How CNS Pharmaceuticals Inc. stock performs after earningsJuly 2025 Summary & Detailed Earnings Play Alerts - Улправда

Jan 08, 2026

Should I hold or sell CNS Pharmaceuticals Inc. stock in 2025Earnings Risk Summary & Reliable Volume Spike Alerts - Улправда

Jan 08, 2026

Dividend Watch: How CNS Pharmaceuticals Inc. stock performs in rate cut cycles2025 Investor Takeaways & Accurate Trade Setup Notifications - Улправда

Jan 08, 2026

Jan 02, 2026